Trade Summary

3 days ago, Coyne Terrance P., serving as EVP & CFO at Royalty Pharma plc (RPRX), sold 64,399 shares at $53.98 per share, for a total transaction value of $3,476,116.34.

This sale represents a 100.00% decrease in Coyne Terrance P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:48 PM ET, 2 days after the trade was made.

Royalty Pharma plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.